In a regulatory filing, Amneal Pharmaceuticals (AMRX) director Gautam Patel disclosed the sale of 62,590 class A common shares of the company on January 8 at a price of $8.01 per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRX: